Complete remission of treatment‐refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin‐2 therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|4|1156-1158

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.4, 2015-04, pp. : 1156-1158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biweekly gemcitabine therapy induces complete remission in cutaneous angiosarcoma resistant to multiple anticancer drugs

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 12, 2015-12 ,pp. : 1197-1198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of an Angiosarcoma of the Nose with Radiation Therapy

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-10 ,pp. : 570-575

Karger

Access to resources Recommend Favorite

Refractory Angiosarcoma of the Breast with VEGFR2 Upregulation Successfully Treated with Sunitinib

By  

THE BREAST JOURNAL, Vol. 21, Iss. 2, 2015-03 ,pp. : 205-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Trial of Systemic Recombinant Interleukin-2 in the Treatment of Refractory Nasopharyngeal Carcinoma

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 110-115

Karger

Access to resources Recommend Favorite

Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1010-1017

John Wiley & Sons Inc

Access to resources Recommend Favorite